Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid
- 1 December 1985
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 24 (12) , 1257-1259
- https://doi.org/10.1016/0028-3908(85)90163-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)Neuropharmacology, 1985
- Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTPEuropean Journal of Pharmacology, 1984
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetra-hydropyridine (MPTP) to Parkinson's diseaseBiochemical Pharmacology, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Extracellular ascorbic acid increases in striatum following systemic amphetaminePharmacology Biochemistry and Behavior, 1984
- Ascorbic acid and the binding of DA agonists to neostriatal membrane preparationsNeuropharmacology, 1983
- Parkinson's disease: A disorder due to nigral glutathione deficiency?Neuroscience Letters, 1982
- Behavioral observation and intracerebral electrochemical recording following administration of amphetamine in ratsPharmacology Biochemistry and Behavior, 1982